ALB and esophageal squamous cell carcinoma: The weekly regimen of cisplatin and albumin-bound paclitaxel combined with radiotherapy has been shown to be safe with manageable toxicity and good antitumor activity in patients with locally advanced esophageal squamous cell carcinoma (20).